|
WO2020260689A1
|
|
New composition containing branched-chain amino acids
|
|
WO2020260700A1
|
|
Composition for the treatment of muscle wasting
|
|
EP3670489A1
|
|
Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof
|
|
WO2019106583A1
|
|
Vial case
|
|
CN111343973A
|
|
IL-8 inhibitors for the treatment of certain sarcomas
|
|
EP3599245A1
|
|
Il-17a binding polypeptides and medical uses thereof
|
|
EP3508199A1
|
|
Immediate-release pharmaceutical compositions containing ketoprofen lysine salt
|
|
EP3498269A1
|
|
C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain
|
|
EP3538077A1
|
|
Preparation of coated cranberry granules composition with stable pacs content
|
|
EP3476390A1
|
|
Il-8 inhibitors for use in the treatment of sarcomas
|
|
AU2017339942A1
|
|
Prevention and treatment of diabetic nephropathy
|
|
KR20190039948A
|
|
≪ RTI ID = 0.0 > GPR40 < / RTI > and GPR120-
|
|
AU2017286989A1
|
|
Controlled volume dropper
|
|
EP3409277A1
|
|
Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections
|
|
EP3406259A1
|
|
Neurotrophins for use in the treatment of hearing loss
|
|
CA3009438A1
|
|
Il-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy
|
|
EP3342407A1
|
|
Il-8 inihibitors for use in the treatment of some urological disorders
|
|
CN107921105A
|
|
8 inhibitor of IL is used for the purposes for treating some urinary disorders
|
|
EP3280654A1
|
|
Method for manufacturing a dispensing device for eye drops
|
|
US2018133053A1
|
|
Dispensing device for eye drops
|
